SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-016948
Filing Date
2022-04-29
Accepted
2022-04-29 16:09:41
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A ny20002921x3_defa14a.htm DEFA14A 10825
2 ny20002921x3_nc1.jpg GRAPHIC 1902373
3 ny20002921x3_nc2.jpg GRAPHIC 1354360
  Complete submission text file 0001140361-22-016948.txt   4200431
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36829 | Film No.: 22875376
SIC: 2834 Pharmaceutical Preparations